The cytoplasmic Purkinje onconeural antigen cdr2 down-regulates c-Myc function: implications for neuronal and tumor cell survival

被引:87
作者
Okano, HJ [1 ]
Park, WY [1 ]
Corradi, JP [1 ]
Darnell, RB [1 ]
机构
[1] Rockefeller Univ, Mol Neurooncol Lab, New York, NY 10021 USA
关键词
Purkinje neurons; cerebellar degeneration; c-Myc function; paraneoplastic neurological disease; leucine zipper protein;
D O I
10.1101/gad.13.16.2087
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Paraneoplastic cerebellar degeneration (PCD) is a disorder in which breast or ovarian tumors express an onconeural antigen termed cdr2, which normally is expressed in cerebellar Purkinje neurons. This leads to an immune response to cdr2 that is associated with tumor immunity and autoimmune cerebellar degeneration. We have found that cdr2, a cytoplasmic protein harboring a helix-leucine zipper (HLZ) motif, interacts specifically with the HLZ motif of c-Myc. Both proteins colocalize in the cytoplasm of adult cerebellar Purkinje neurons, and coimmunoprecipitate from tumor cell lines and cerebellar extracts. cdr2 down-regulates c-Myc-dependent transcription in cotransfection assays, and redistributes Myc protein in the cytoplasm. Disease antisera from six of six PCD patients specifically blocked the interaction between cdr2 and c-Myc in vitro. These data indicate that cdr2 normally sequesters c-Myc in the neuronal cytoplasm, thereby down-regulating c-Myc activity, and suggest a mechanism whereby inhibition of cdr2 function by autoantibodies in PCD may contribute to Purkinje neuronal death.
引用
收藏
页码:2087 / 2097
页数:11
相关论文
共 61 条
[1]   Tumor-specific killer cells in paraneoplastic cerebellar degeneration [J].
Albert, ML ;
Darnell, JC ;
Bender, A ;
Francisco, LM ;
Bhardwaj, N ;
Darnell, RB .
NATURE MEDICINE, 1998, 4 (11) :1321-1324
[2]   MAD - A HETERODIMERIC PARTNER FOR MAX THAT ANTAGONIZES MYC TRANSCRIPTIONAL ACTIVITY [J].
AYER, DE ;
KRETZNER, L ;
EISENMAN, RN .
CELL, 1993, 72 (02) :211-222
[3]  
BAI MK, 1994, ONCOLOGY, V51, P314
[4]  
Bao JX, 1996, ONCOGENE, V12, P2171
[5]   MYC AND MAX ASSOCIATE INVIVO [J].
BLACKWOOD, EM ;
LUSCHER, B ;
EISENMAN, RN .
GENES & DEVELOPMENT, 1992, 6 (01) :71-80
[6]   c-myc is not useful as prognostic immunohistochemical marker in cutaneous melanoma [J].
Böni, R ;
Bantschapp, O ;
Müller, B ;
Burg, G .
DERMATOLOGY, 1998, 196 (03) :288-291
[7]   SELECTIVE EXTRACTION OF SMALL AND LARGE MOLECULES FROM THE CEREBROSPINAL-FLUID BY PURKINJE NEURONS [J].
BORGES, LF ;
ELLIOTT, PJ ;
GILL, R ;
IVERSEN, SD ;
IVERSEN, LL .
SCIENCE, 1985, 228 (4697) :346-348
[8]  
Corradi JP, 1997, J NEUROSCI, V17, P1406
[9]   Regulation of class I MHC gene expression in the developing and mature CNS by neural activity [J].
Corriveau, RA ;
Huh, GS ;
Shatz, CJ .
NEURON, 1998, 21 (03) :505-520
[10]  
CRAIG RW, 1993, CELL GROWTH DIFFER, V4, P349